Document is current
Any future updates will be listed below
-
Authors
Da Silva Domingues, Vital https://orcid.org/0000-0001-7339-0220
Rodrigues, Ana M. https://orcid.org/0000-0003-2046-8017
Dias, Sara S. https://orcid.org/0000-0001-6782-7481
Delgado, Luís https://orcid.org/0000-0003-2375-9071
Barkoudah, Ebrahim https://orcid.org/0000-0001-8224-5121
Branco, Jaime https://orcid.org/0000-0001-7024-4375
Canhão, Helena https://orcid.org/0000-0003-1894-4870
-
Funding
Funding for this research was provided by:
Sociedade Portuguesa de Reumatologia/Pfizer (PT2017_002)
- License Information
-
More Information
Article History
Received: 2 September 2020
Accepted: 13 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Dr. Barkoudah reports research support from National Institutes of Health/National Heart, Lung, and Blood Institute, Bristol Myers Squibb and Janssen, payments made to Brigham and Women’s Hospital for performing clinical endpoints and Advisory Board fees from Bristol Myers Squibb, Janssen, Novartis, Pfizer and Portola, and travel expenses from Alexion; all outside he presented work. No other conflict of interest was identified.
: Approved by NOVA Medical School Ethics Committee and the National Committee for Data Protection.
